1. Home
  2. ACLS vs SUPN Comparison

ACLS vs SUPN Comparison

Compare ACLS & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$86.08

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.65

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
SUPN
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
ACLS
SUPN
Price
$86.08
$51.65
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$102.25
$61.60
AVG Volume (30 Days)
605.3K
754.8K
Earning Date
02-17-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.25
N/A
Revenue
$853,135,000.00
$681,539,000.00
Revenue This Year
N/A
$8.18
Revenue Next Year
$6.84
$22.15
P/E Ratio
$20.26
N/A
Revenue Growth
N/A
4.54
52 Week Low
$40.40
$29.16
52 Week High
$102.93
$57.65

Technical Indicators

Market Signals
Indicator
ACLS
SUPN
Relative Strength Index (RSI) 43.04 61.38
Support Level $79.35 $47.29
Resistance Level $91.01 $49.71
Average True Range (ATR) 4.53 1.40
MACD -1.34 0.05
Stochastic Oscillator 26.40 100.00

Price Performance

Historical Comparison
ACLS
SUPN

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: